Peter Welford
Stock Analyst at Jefferies
(1.19)
# 1713
Out of 5,329 analysts
20
Total ratings
66.67%
Success rate
7.42%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
GSK GSK | Downgrades: Hold | n/a | n/a | n/a | 3 | Nov 12, 2024 | |
NVS Novartis | Downgrades: Hold | n/a | n/a | n/a | 2 | Sep 3, 2024 | |
AZN AstraZeneca | Downgrades: Hold | n/a | n/a | n/a | 4 | Jan 3, 2024 | |
GLPG Galapagos | Upgrades: Hold | 49 48 | 26.79 | 76.19% | 3 | Jan 23, 2023 | |
GMAB Genmab | Downgrades: Hold | n/a | n/a | n/a | 1 | Sep 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 28 | n/a | n/a | 1 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 6 | Feb 1, 2019 |